X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4130) 4130
Book Review (345) 345
Publication (242) 242
Book Chapter (4) 4
Conference Proceeding (4) 4
Magazine Article (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4042) 4042
female (3894) 3894
index medicus (3870) 3870
ovarian neoplasms - pathology (2409) 2409
middle aged (2378) 2378
cystadenocarcinoma, serous - pathology (2220) 2220
aged (1922) 1922
adult (1751) 1751
oncology (1750) 1750
neoplasm staging (1180) 1180
cancer (1170) 1170
prognosis (1169) 1169
ovarian cancer (1109) 1109
obstetrics & gynecology (1108) 1108
carcinoma (999) 999
cystadenocarcinoma, serous - metabolism (849) 849
cystadenocarcinoma, serous - genetics (847) 847
aged, 80 and over (837) 837
pathology (836) 836
ovarian neoplasms - genetics (830) 830
ovarian neoplasms - metabolism (774) 774
immunohistochemistry (746) 746
retrospective studies (663) 663
tumors (605) 605
endometrial neoplasms - pathology (577) 577
survival rate (550) 550
cystadenocarcinoma, serous - surgery (545) 545
follow-up studies (514) 514
cystadenocarcinoma, serous - drug therapy (499) 499
chemotherapy (495) 495
cystadenocarcinoma, serous - mortality (488) 488
ovarian neoplasms - drug therapy (486) 486
adenocarcinoma, clear cell - pathology (479) 479
survival (478) 478
surgery (473) 473
expression (465) 465
ovarian neoplasms - surgery (455) 455
ovarian neoplasms - mortality (445) 445
neoplasm grading (409) 409
adenocarcinoma, mucinous - pathology (406) 406
cystadenocarcinoma, papillary - pathology (376) 376
diagnosis, differential (358) 358
carcinoma, endometrioid - pathology (351) 351
cystadenocarcinoma, serous - diagnosis (350) 350
male (342) 342
adenocarcinoma (340) 340
cystadenocarcinoma, serous - secondary (321) 321
cystadenocarcinoma - pathology (318) 318
biomarkers, tumor - metabolism (316) 316
antineoplastic combined chemotherapy protocols - therapeutic use (304) 304
ovarian neoplasms - diagnosis (294) 294
analysis (291) 291
treatment outcome (291) 291
abridged index medicus (287) 287
gene expression regulation, neoplastic (282) 282
ovary (281) 281
diagnosis (279) 279
neoplasm invasiveness (277) 277
mutation (275) 275
metastasis (272) 272
young adult (270) 270
endometrial cancer (265) 265
women (253) 253
research (249) 249
peritoneal neoplasms - pathology (248) 248
cystadenocarcinoma (247) 247
ovarian carcinoma (247) 247
adolescent (246) 246
neoplasm recurrence, local - pathology (240) 240
cystadenocarcinoma, mucinous - pathology (233) 233
biomarkers, tumor - analysis (232) 232
pancreatic neoplasms - pathology (231) 231
uterine neoplasms - pathology (230) 230
breast-cancer (227) 227
cell line, tumor (226) 226
animals (225) 225
cystadenocarcinoma, serous - therapy (224) 224
p53 (223) 223
immunoenzyme techniques (221) 221
obstetrics and gynecology (218) 218
survival analysis (215) 215
tumor cells, cultured (215) 215
disease-free survival (210) 210
lymphatic metastasis (210) 210
gene expression (209) 209
care and treatment (206) 206
medicine & public health (204) 204
combined modality therapy (203) 203
article (200) 200
genetic aspects (199) 199
hematology, oncology and palliative medicine (199) 199
fallopian tube neoplasms - pathology (191) 191
adenocarcinoma - pathology (189) 189
ovarian neoplasms - therapy (188) 188
risk factors (186) 186
management (182) 182
neoplasms, glandular and epithelial - pathology (178) 178
adenocarcinoma, clear cell - mortality (177) 177
mice (177) 177
cell biology (176) 176
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3721) 3721
Chinese (190) 190
Japanese (67) 67
German (49) 49
French (35) 35
Russian (25) 25
Polish (11) 11
Spanish (10) 10
Italian (7) 7
Hungarian (4) 4
Bulgarian (3) 3
Danish (3) 3
Romanian (3) 3
Czech (2) 2
Hebrew (2) 2
Dutch (1) 1
Korean (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Pathology, ISSN 0022-3417, 12/2013, Volume 231, Issue 4, pp. 449 - 456
BRAF and KRAS mutations in ovarian serous borderline tumours ( OSBTs ) and ovarian low‐grade serous carcinomas ( LGSCs ) have been previously described.... 
mutation | deep sequencing | ovarian low‐grade serous carcinoma | KRAS | BRAF | serous borderline tumour | COLD‐PCR | COLD-PCR | ovarian low-grade serous carcinoma | SURVIVAL | NEOPLASMS | IMPLANTS | PATHOLOGY | PATHOGENESIS | CANCER GENOMICS | ONCOLOGY | RAS MUTATIONS | PROTEIN MUTATIONS | EXPRESSION | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | DNA Mutational Analysis - methods | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Adult | Female | Cell Death - drug effects | Tumor Cells, Cultured | High-Throughput Nucleotide Sequencing - methods | MAP Kinase Kinase Kinases - antagonists & inhibitors | Neoplasm Proteins - genetics | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Proto-Oncogene Proteins B-raf - genetics | Benzimidazoles - pharmacology | Neoplasm Recurrence, Local - genetics | Aged | Protein Kinase Inhibitors - pharmacology | DNA, Neoplasm - genetics | Mutation | Cystadenoma, Serous - genetics | Cystadenoma, Serous - pathology | Proteins | Relapse | Carcinoma | Gene mutations | Genomics | Analysis | Denaturation | Cancer | Diseases | Index Medicus | KRAS mutation | Ovarian low-grade serous carcinoma | Serous borderline tumor | Deep sequencing | KRAS G12V | BRAF mutation | Full COLD-PCR
Journal Article
Journal Article
Cancer Cell, ISSN 1535-6108, 12/2013, Volume 24, Issue 6, pp. 751 - 765
Journal Article
Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 1093 - 11
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, pp. e80063 - e80063
Ovarian cancer is an immune reactive malignancy with a complex immune suppressive network that blunts successful immune eradication. This suppressive... 
GYNECOLOGIC-ONCOLOGY-GROUP | NEU-TRANSGENIC MICE | PROGNOSTIC-FACTORS | REGULATORY CELLS | DENDRITIC CELLS | MULTIDISCIPLINARY SCIENCES | TRANSCRIPTION FACTOR FOXP3 | TUMOR | INDUCTION | AUTOIMMUNE-DISEASE | CARCINOMA | CD8-Positive T-Lymphocytes - pathology | Prognosis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - genetics | Ovarian Neoplasms - mortality | CD4-Positive T-Lymphocytes - pathology | Cystadenocarcinoma, Serous - pathology | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Ovarian Neoplasms - genetics | Interleukin-2 Receptor alpha Subunit - genetics | Aged, 80 and over | Adult | Female | Cystadenocarcinoma, Serous - immunology | Interleukin-2 Receptor alpha Subunit - immunology | Gene Expression | Ovary - pathology | Ovary - immunology | Immunophenotyping | Survival Analysis | Cystadenocarcinoma, Serous - mortality | Lymphocyte Count | Aged | CD8-Positive T-Lymphocytes - immunology | Forkhead Transcription Factors | Ovarian Neoplasms - immunology | Transcription factors | Ovarian carcinoma | CD8 antigen | Effector cells | Cytotoxicity | Lymphocytes T | Malignancy | Clinical outcomes | Ovarian cancer | Immunology | Lymphocytes | Immunotherapy | CD25 antigen | Foxp3 protein | Cell survival | Immunoregulation | Histology | CD3 antigen | Patients | Survival | CD4 antigen | Studies | Chemotherapy | Medical prognosis | Immunofluorescence | Cancer | Tumors | Index Medicus
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 02/2007, Volume 31, Issue 2, pp. 161 - 169
Journal Article
Nature Genetics, ISSN 1061-4036, 07/2016, Volume 48, Issue 7, pp. 758 - 767
Journal Article